2021 Speakers

Christophor Jones

Director of Biology

Terns Pharmaceuticals

Elias Papatheodoru

Chief Executive Officer

Genkyotex

Maurizio Bonacini

MD, AGAF

Mission Gastroenterology & Hepatology

Richard Peneck

Executive Director of Clinical Science

Metacrine

Pnina Fishman

Chief Executive Officer

CanFite

Scott Harris

Chief Medical Officer

Altimmune

Susan Luong

Scientist

Aligos Therapeutics

Winston Dunn

Transplant Hepatologist

University of Kansas Medical Center

Davide Povero

Assistant Professor in Biochemistry and Molecular Biology

Mayo Clinic

Eva Castagnetti

Chief Executive Officer

Resalis Therapeutics

Melissa Miller

Director of Human Genetics

Pfizer

Pietro Scalfaro

Chief Medical Officer

Enyo Pharma

Becky Taub, Madrigal Pharmaceuticals, NASH Conference Speaker

Becky Taub

Founder, Director, CEO & President

Madrigal Pharmaceuticals

David Moller

Chief Scientific Officer

Poxel Pharma

Markus Mayer

Vice President of R&D

Alentis

Stephen Rossi

Chief Development Officer

Northsea Therapeutics

Erik Tillman

Principal Scientist

Akero Therapeutics

Joseph Sarret

Chief Executive Officer

CohBar

Kenneth Cusi

Professor of Medicine & Chief, Division of Endocrinology

Diabetes and Metabolism, The University of Florida

Yury Popov

Division of Gastroenterology, Hepatology & Nutrition

Harvard Medical School

Barry Crittenden

Executive Director, Clinical Research

Terns Pharmaceuticals

Hannah K. Drescher

Postdoctoral Research Fellow at Gastrointestinal Unit

Harvard Medical School

Jiming Ye

Chief Scientific Officer

KBI

Liat Hayardeny

Chief Scientific Officer

Galmed Pharmaceuticals

Bart Staels

Professor

University of Lille

Dr. Erin Quirk

President & Chief Medical Officer

Terns Pharmaceuticals

Marie O’Farrell

Vice President of Research & Development

Sagimet

Rhianna Laker

Scientist

AstraZeneca

Andrew Billin

Senior Director - Biomarker Sciences

Gilead

Cynthia Arbeeny

Chief Scientific Officer

Mitotherapeutix

Eduardo Martins

Chief Medical Officer

Sagimet Biosciences

James Trevaskis

Senior Director of Biology & Head of Fibrosis Research

Gilead

Ariel Feldstein

Professor

University of California San Diego

Axel Haupt

Vice President for Diabetes Clinical Investigation & Insulin & Incretin Research

Eli Lilly

Christian Meyer

Global Director of Scientific Affairs, Diabetes & Metabolism

Merck

Roberto Calle

Executive Medical Director

Regeneron

Alistar Smith

Executive Medical Director; Medical & Scientific Management

Syneos Health

Daniel Lindén

Senior Principal Scientist

AstraZeneca

Nikolaos Perakakis

Professor of Metabolic & Vascular Medicine, Carl Gustav Carus Faculty of Medicine

TU University of Dresden

William Esler

Senior Director

Pfizer

Gerardo Rodriguez

Senior Medical Director

Inventiva Phama

James E Brown

DVM

DURECT Corporation

Jeff McIntyre

Advocate for Public Health, Public Policy & The Public Interest

Global Liver

Joachim Musaeus

EMA Product Lead/Deputy Head of Rheumatology, Gastroenterology and Immunology

European Medicines Agency

Dr. Adrian M. Di Bisceglie

Chief Medical Officer

HighTide Therapeutics

Kendra Bence

Executive Director

Pfizer

Michael Cooreman

Chief Medical Officer

Inventiva Pharma

Paul Monga

Assistant Dean, Vice Chair & Endowed Chair of Experimental Pathology

University of Pittsburgh

Abbas Bandukwala

Science Policy Analyst, Biomarker Qualification Program

FDA

Chandra Saravan

Director of Discovery & Investigative Safety

Novartis

Juliette Chen

Director – Global Evidence and Outcomes

Takeda

Tania Kamphaus

NIMBLE Program Officer & Metabolic Diseases Program Lead

Foundation for NIH